Hjem › Amyloidose › Maryland
Amyloidose kliniske forsøg i Maryland
7 studier for Amyloidose søger deltagere på steder i Maryland.
Byer i Maryland
Officiel studietekst (engelsk)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Baltimore
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 23. sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Baltimore
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 16. sep. 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Baltimore
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 15. sep. 2026 · NCT07223203ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Baltimore
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 8. sep. 2026 · NCT04561518Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Maryland Medical Center, Baltimore
- Johns Hopkins University, Baltimore
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06563895Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 19. maj 2026 · NCT06974877MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Johns Hopkins University, Baltimore
RekruttererFase 3
Alder 18 til 90 · Alle køn · Opdateret 27. mar. 2026 · NCT06128629Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.